Sun Pharma sued by Mayne Pharma for patent infringement
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-07-26 10:33 GMT | Update On 2024-08-05 19:05 GMT
Advertisement
Mayne Pharma has initiated legal action against Sun Pharma of India, alleging patents infringement related to a certain product designed to alleviate menopause-related vaginal pain, the Australian pharmaceutical company announced on Thursday.
The lawsuit was filed in the United States District Court for New Jersey, where Mayne Pharma claims that Sun Pharma has violated all 20 Orange Book-listed patents associated with IMVEXXY. IMVEXXY is a vaginal insert specifically intended to reduce pain during sexual intercourse following menopause.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.